E
Actavia Life Sciences, Inc. RASP
$0.004 -$0.0285-87.69%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2024 12/31/2023 09/30/2023 06/30/2023 03/31/2023
Net Income -406.60K -4.44M -4.44M -4.44M -4.98M
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges 34.60K 182.90K 184.20K 195.00K 784.90K
Total Other Non-Cash Items 26.40K 3.88M 3.88M 3.89M 3.81M
Change in Net Operating Assets 279.20K 327.20K 371.10K 156.10K 194.30K
Cash from Operations -66.40K -54.40K -8.50K -205.70K -195.10K
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued 98.00K 80.00K 110.00K 280.00K 280.00K
Total Debt Repaid -32.30K -53.90K -65.80K -82.30K -110.80K
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 65.70K 26.10K 44.20K 197.70K 169.20K
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -800.00 -28.30K 35.70K -8.00K -25.90K
Weiss Ratings